# Hongsheng Capital

> Hongsheng Capital is a VC fund backing Health Care, Medical and Hospital. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 7
- Last investment: Mar 2026
- Lead investor: 71%
- Last updated: Aug 2026

Hongsheng Capital is a VC fund focused on Health Care and Medical. Hongsheng Capital focuses on equity investment in the healthcare industry.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 43% |
| Medical | 2 | 29% |
| Hospital | 2 | 29% |
| Biotechnology | 2 | 29% |
| Biopharma | 1 | 14% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 2 | 29% |
| Series A | 2 | 29% |
| Seed | 1 | 14% |
| Series B | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Fuxing Jiaer | Fuxing Jiaer is committed to building an evidence-based pediatric nutritional intervention system. |  | Angel | Mar 31, 2026 |  |
| Noah Source Medical | Noah Source Medical is a cutting-edge technological business that specializes in producing high-end full-spectrum flow cytometers through independent research and development. |  | Angel | Mar 30, 2026 |  |
| Yili Pharmaceutical | Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $14.5M | Seed | Mar 12, 2026 |  |
| Methuselah | Methuselah is a research and development manufacturer of medical nutritional food. | $15M | Series B | Aug 04, 2025 |  |
| Warrenville | Warrenville is a forward-thinking high-tech enterprise dedicated to advancing hospital intelligence and automation through cutting-edge technologies. With a focus on improving healthcare delivery, the company develops innovative solutions that streamline hospital operations, enhance patient care, and optimize resource management. |  | Series A | Jun 18, 2025 |  |
| Enokiko | Enokiko is a provider of synthetic biology platforms oriented to the study, creation, and manufacturing of environmentally friendly biological products. | $20.6M | Series A | Mar 03, 2025 |  |
| Methuselah | Methuselah is a research and development manufacturer of medical nutritional food. | $27.5M | Series B | Feb 19, 2025 |  |

7 of 7 investments shown.

## Co-investors
- [Highlight Capital](https://shizune.co/investors/profile/highlight-capital-llc) — VC Fund, 2 deals together
- [Bailian Commercial Investment](https://shizune.co/investors/profile/bailian-commercial-investment) — VC Fund, 1 deal together
- [Bioclub](https://shizune.co/investors/profile/bioclub) — VC Fund, 1 deal together
- [CICC Capital](https://shizune.co/investors/profile/cicc-capital) — VC Fund, 1 deal together
- [Confitop Capital](https://shizune.co/investors/profile/confitop-capital) — VC Fund, 1 deal together
- [Fengqiao Capital](https://shizune.co/investors/profile/fengqiao-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Infrastructure Investors in Asia](https://shizune.co/investors/infrastructure-investors-asia)

## FAQ

### What does Hongsheng Capital invest in?

Hongsheng Capital invests primarily in Health Care, Medical and Hospital startups, most often at Angel and Series A stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hongsheng Capital last invest?

The most recent investment recorded for Hongsheng Capital closed in Mar 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co